LINK ALTERNATIF MBL77 SECRETS

Not all people with CLL need therapy. Irrespective of all latest advances, the iwCLL nonetheless suggests watchful observation for patients with asymptomatic condition.86 This suggestion relies on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104